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Retinoic acid (RA) plays an important role in the balance of inflammation and tolerance in 
T cells. Furthermore, it has been demonstrated that RA facilitates IgA isotype switching 
in B cells in vivo. However, it is unclear whether RA has a direct effect on T-independent 
B cell responses in vivo. To address this question, we generated a mouse model where 
RA signaling is specifically silenced in the B cell lineage. This was achieved through 
the overexpression of a dominant negative receptor α for RA (dnRARα) in the B cell 
lineage. In this model, we found a dramatic reduction in marginal zone (MZ) B cells and 
accumulation of transitional 2 B cells in the spleen. We also observed a reduction in B1 
B cells in the peritoneum with a defect in the T-independent B cell response against 
2,4,6-trinitrophenyl. This was not a result of inhibited development of B cells in the bone 
marrow, but likely the result of both defective expression of S1P1 in MZ B cells and a 
defect in the development of MZ and B1 B cells. This suggests that RARα expression 
in B cells is important for B cell frequency in the MZ and peritoneum, which is crucial for 
the generation of T-independent humoral responses.
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inTrODUcTiOn
B cells play an essential role in the protection against infection, contributing to both innate and 
adaptive immune responses. They are derived from the bone marrow and undergo a developmental 
process that results in terminally differentiated plasma cells, acquiring antibody producing capacity, 
which mediates the neutralization and removal of microbes and infected cells (1). When exposed 
to a cognate antigen, B cells are capable of responding in a T cell-independent manner via their 
differentiation into short-lived plasma cells. These short-lived plasma cells produce a limited array 
of Ig isotypes; in the first instance, they produce IgM antibodies and then, to a lesser extent, produce 
IgG antibodies. In addition, the antibodies produced by short-lived plasma cells have not undergone 
affinity maturation, resulting in low specificity of responses (2). The initial T-independent response 
normally dissipates after a week (2).
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An optimal T-independent B cell response requires two 
different subsets of B cells; marginal zone (MZ) B cells and B1 
B cells. MZ B cells are produced in the spleen and result from the 
differentiation of immature bone marrow-derived B cells (3). MZ 
B cells are derived from immature Transitional 2 (T2) B cells (4) 
in a process mediated by high expression of delta-like 1 expressed 
in splenic venules (5) and NF-κB signaling (6).
In contrast, it is known that B1 B cells are produced in the 
peritoneal and pleural cavities (3); however, the signaling mecha-
nisms involved in the development of this subset are not fully 
understood. Nonetheless, it is clear that B1 B cells are developed 
by the first weeks following birth (7) and maintained during 
adulthood by self-renewal (8).
B1 B cells play an important role in IgA gut humoral responses 
following migration of these cells from the peritoneum to the 
lamina propria of the intestine. In the lamina propria, B1 B cells 
differentiate into polyspecific IgA-plasma cells in a process that 
is dependent on IL-5 (9). Thus, MZ and B1 B cells are key to 
the production of natural antibodies and maintenance of tissue 
homeostasis.
Several factors regulate B-cell growth, survival, maturation, 
and migration. It has been shown that retinoic acid (RA), a 
product derived from vitamin A, plays an important role in 
these events. Vitamin A deficiency drastically increases the 
mortality rate as a result of measles infection (10) or diarrhea 
(11). In addition, supplementation with vitamin A reduces the 
morbidity of these and others infectious diseases (12), suggesting 
that vitamin A plays an important role in T and B cell-mediated 
immunity. In animal models, it has been demonstrated that 
vitamin A deficiency reduces antibody titers against tetanus 
toxin, which is a T-dependent B-cell response (13, 14). Vitamin 
A deficiency has also been shown to decrease antigen-specific 
IgG responses (15, 16). Similarly, lack of vitamin A reduces the 
levels of antibodies in T-cell-independent type 2 (TI2) responses 
when pneumococcal polysaccharide is used as an antigen (17). 
Antibody titers are rescued after the administration of vitamin A, 
indicating that there is a correlation between levels of vitamin A 
and the production of an effective TI2 response (18).
Because of the significant effects of vitamin A on B cell differ-
entiation, it has been evaluated as an adjuvant for augmentation of 
the immune response. In fact, RA in combination with IL-15 can 
induce potent cellular and humoral responses (19). In addition, it 
has been shown that the T cell-independent type 1 (TI1) response 
is normal in vitamin A-deficient rats, whereas TI2 is abrogated 
(20). This suggests that the reduction in antibody production is 
due to a defect in the response to specific antigens rather than an 
intrinsic defect in the synthesis of antibodies. Moreover, the lack 
of an effective TI2 response could be explained by the reduction 
in MZ B cells and B1 B cells in vitamin A-deficient mice (21). 
Thus, RA may play an important role in TI2 responses.
The development of B cells is also regulated by RA (22). B cell 
progenitors treated with RA differentiate into mature B cells, 
reducing the time of differentiation without affecting the prolif-
eration of the progenitors (22). These results were corroborated 
in vivo using mice treated with all-trans RA (ATRA). Mice treated 
with ATRA display increased numbers of mature B-cells in the 
bone marrow and spleen, despite exhibiting a decreased number 
of B-cells precursors. RA acts through the RA receptor α (RARα) 
to induce Pax5, a key transcription factor in the maturation of 
B cells and a repressor of plasma cell differentiation (22, 23).
Here, we highlight the importance of RA signaling in the 
development of T cell-independent B cell immune responses. 
Using a genetic approach, by overexpressing a dominant-negative 
form of RARα specifically in the B cell compartment (24), we 
demonstrate that RA signaling in B cells is required for the 




These studies were approved and conducted in accredited facili-
ties in accordance with The Home Office UK Animals (Scientific 
Procedures) Act 1986 (Home Office license number PPL 70/7102).
Mice and immunizations
C57BL/6 (H-2b) mice were purchased from Harlan Laboratory. 
CD19Cre mice were purchased from the Jackson Laboratory. 
The dominant negative (dn) RARα mice have been previously 
described (25). We generated the dnRARfl/flCD19Cre/+ (heterozy-
gous form for CD19Cre), in a manner similar to previous reports 
(24). The CD19Cre/+ control mice are haplosufficient and had a 
normal B cell compartment as previous described (24). To evalu-
ate T-independent immune responses, mice aged 8–10  weeks 
were immunized with 50  µg of the hapten (Tri-4-hydroxy-3-
nitrophenyl) acetyl (TNP)-Ficoll (Biosearch Technology). To 
study T-dependent humoral immune responses, 50 µg of TNP-
KLH (Biosearch Technology) adsorbed in alum was injected i.p. 
in a volume of 200 µl. These studies were approved and conducted 
in accredited facilities in accordance with the United Kingdom 
Animals (Scientific Procedures) Act 1986 (Home Office license 
no. PPL 70/7102). All animals were cohoused and maintained in 
a specific pathogen-free facility at King’s College London.
cell Preparation
To analyze B cells, single-cell suspensions of lymphocytes were 
prepared from spleens by mechanical disruption in DPBS fol-
lowed by passing the cells through a 70 µm cell strainer. Cells were 
collected by centrifugation (5 min, 500 × g, 4°C) and red blood 
cells were lysed (2 min, 37°C) using RBC Lysis buffer (BioLegend). 
Total number of cells and cell viability were determined using a 
hemocytometer and trypan blue. For isolation of peritoneal cells, 
the peritoneal cavity was flushed with 5 ml warm (37°C) PBS, 2% 
BSA, 2 mM EDTA, 0.02% sodium azide, and 10 U/ml Heparin.
antibodies and Flow cytometry
Antibodies against the following antigens were used: anti-mouse 
B220 (clone 6B2), CD38 (clone 90), IgM (clone 11–41), CD24 
(clone M1/69), CD21/35 (clone 7E9), CD23 (clone B3B4), and 
IgD (clone 11-26c) from BD Biosciences. Anti-mouse CD5 (clone 
53-7.3) and CD11b (clone M1/70) from Biolegend. Anti-mouse 
CD11a (integrin αL, clone M17/4), CD18 (integrin β2, clone 
M18/2), CD29 (integrin β1, clone HMb1-1), and CD49d (integrin 
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α4, clone R1-2) from eBioscience. Murine cells were resuspended 
in DPBS + 3% FCS and stained for 30 min at 4°C with different 
anti-mouse antibodies in the presence of anti-mouse TruStain fcX 
(Biolegend). Control samples were labeled with matched isotype 
control antibodies. The samples were resuspended in Sytox Blue 
Dead Cell Stain (1:1,000 in DPBS; Invitrogen) before acquisition. 
Samples were acquired by flow cytometry (BD LSRFortessa 
cell analyser, Becton Dickinson) with FACSDiva software v6.2 
(Becton and Dickinson) and data were analyzed using FlowJo 
(Tree Star) software.
Purification of B cell subsets
B cells were purified from the spleens of dnRARαCD19Cre or 
littermate control mice by negative selection using CD43 micro-
beads (Miltenyi Biotech) according to the manufacturer’s instruc-
tions. Purified splenic B cells were stained with anti-CD21/35, 
anti-CD24, anti-CD23, and anti-IgM as described previously 
(26). Sytox was added to exclude dead cells. Cells were sorted by 
BD FACSAria II (BD Biosciences). In some cases, MZ B cells were 
cultured with 1µM of LE135 (Tocris Biosciences), an antagonist 
for RAR receptors, for 24 h as previously described (27).
real-time Pcr
Total RNA was isolated from purified B cells using MiniKit 
RNeasy columns (QIAGEN) with a DNase-I treatment step. One 
microgram of DNA-free RNA was reverse transcribed to cDNA 
using Omniscript RT (QIAGEN). TaqMan gene expression assays 
containing FAM dye-labeled TaqMan MGB probe was used for 
mouse S1pr1 (Mm02619656_s1), RARα (Mm01296312_m1), 
RARβ (Mm01319677_m1), and RARγ (Mm00441091_m1) 
in multiplex with primer-limited assays for glyceraldehyde-3- 
phosphate dehydrogenase (GAPDH) endogenous control 
containing VIC/MGB probes. Real-time quantification was per-
formed using TaqMan gene expression master mix on a Bio-Rad 
CFX96 optical reaction module on a C1000 thermal cycler. Data 
were analyzed using CFX Manager Software (Bio-Rad).
Microscopy/immunofluorescence
Tissue was then snap frozen in OCT Tissue-Tek freezing medium 
(Sakura). Cryostat sections of 7  µm were air dried, fixed with 
acetone, and washed in DPBS. Blocking was performed with 20% 
normal horse serum (PAA Laboratories Inc.) for 15 min at room 
temperature. Sections were incubated with biotin-conjugated 
anti-mouse IgM (clone 11–41, BD Biosciences), followed by 
streptavidin Alexa Fluor 594 (Life Technologies) or FITC-
conjugated anti-mouse monocyte and macrophage (MOMA; 
Abcam). Negative controls were no primary antibody or stained 
with isotype-matched antibody. Images were acquired on an 
Olympus BX51 microscope using Micro-Manager software (Vale 
Laboratory).
chemotaxis assays
Migration assays were performed as previously described (28). 
FACS-sorted MZ B cells were treated with 1  µM of LE135, or 
left untreated, before analysis using a chemotaxis assay. Transwell 
assays were performed in duplicate, using 100 nM for S1P and 
250 nM for SDF-1 as a chemoattractant. Two mice were pooled 
in each assay, in three independent experiments. It was not 
possible to perform ex vivo chemotaxis assays with cells from 
dnRARαCD19Cre (unpublished data).
elisa analysis
For ELISA analysis, plates were coated with 10 mg/ml TNP-BSA 
overnight in PBS, blocked with PBS + 5% FBS, washed, and then 
1:2,000 diluted serum added at serial 1:2 dilutions. Anti-TNP 
IgG3 (provided by Thomas J. Waldschmidt) and anti-TNP IgM 
(BD Bioscience) was included on each plate as a reference between 
plates and between experiments and used to generate a standard 
curve. Antibody levels were detected with AP-conjugated IgG3 
and IgM (Southern Biotechnology Associates) and developed 
with 1  mg/ml para-nitrophenylphosphate (Sigma-Aldrich) in 
0.05 mM sodium carbonate buffer.
elisPOT analysis
Single-cell preparations were obtained from the spleen and 
the number of TNP-IgM, TNP-IgG3, and TNP-IgG1 antibody-
secreting cells (ASCs) were determined by ELISPOT as previously 
reported (29, 30).
statistics
Results are expressed as mean ± SD. Comparisons between groups 
were performed using T-test for two groups, or one-way ANOVA 
and a Dunnett or Bonferroni posttest for more than two groups. 
Analyses were performed using GraphPad Prism software.
resUlTs
ra signaling in B cells affects the 
Development of MZ B cells
To evaluate the role of RA signaling in T-independent humoral 
responses, we first evaluated the expression of the different RAR 
isoforms in splenic B cell subpopulations. Figure 1A shows the 
gating strategy used to electronically sort splenic B cell subsets, 
T1, T2, MZ, and FO splenic B cells, for analysis of RNA expres-
sion levels of RAR isoforms (all >95% purity). Our results showed 
that these subsets of splenic B cells exclusively express RARα, but 
not the β and γ isoforms (Figure 1B).
To study the functional role of RARα in splenic B cell function, 
we used mice engineered to express a dominant negative form 
of the RARα (RARα403) targeted to the ROSA26 locus down-
stream of a loxP-flanked “stop” cassette. Upon breeding with mice 
expressing Cre recombinase (in this case CD19Cre), RA signaling 
is abrogated in the CD19+ B cell compartment (hereafter denoted 
as dnRARαCD19Cre). We have previously used this approach and 
demonstrated that dnRARα is expressed exclusively in B cells 
from dnRARαCD19Cre mice and is fully functional (24).
We then characterized whether RA signaling in B cells has 
an impact on the development of splenic B cell subsets in vivo. 
We observed an increase in the percentage (Figures 1C,D) and 
absolute number of T2 B cells in the dnRARαCD19Cre mice 
compared with littermate controls (Figure 1E). In contrast, we 
observed a reduction in the percentage and absolute number 
FigUre 1 | The inhibition of ra signaling in B cells impairs the development of MZ B cells. (a) Gating strategy for the different subsets of splenic B cells. 
FO B cells B220+ (CD21/35int IgMint CD24+ CD23+), T1 B cells (B220+ CD21/35low IgM+ CD24+ CD23−), T2 (B220+ CD21/35+ IgM+ CD24+ CD23+), and MZ B cells 
(B220+ CD21/35+ IgM+ CD24+ CD23−). Cells were pre-gated on live, B220+ cells. (B) Quantification of RAR transcript levels in the indicated splenic B cell subsets. 
(c) A representative flow cytometry contour plot of MZ B cells and Carsetti T2 B (B220+ CD21/35+ IgM+ CD24+ CD23+) cells from spleen of dnRARαCD19Cre (right 
panel) or littermate controls (left panel). Cells were pre-gated on live, B220+ CD21/35hi IgM+ cells. (D) Percentage and (e) absolute number of follicular (FO), 
marginal zone (MZ), transitional 1 (T1), and transitional 2 (T2) B cells from spleen of dnRARαCD19Cre or littermate controls. Three independent experiments with at 
least seven mice/group. (F) Histology of the spleen from dnRARαCD19Cre (right panel) or littermate controls (left panel) stained with MOMA-FITC (Green) and 
IgM-biotin plus streptoavidin-alexafluor455 (Red) for MZ analysis. Encircled white area indicates the MZ. The original magnification is 20×. Representative of three 
independent experiments with three mice/group. ***p < 0.001 and ****p < 0.0001.
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FigUre 2 | ra signaling in B cells regulates the expression of s1P1. (a–D) Mean fluorescence intensity of integrins (a) αL, (B) β1, (c) α4, and (D) β2 in 
different splenic subsets B cells from dnRARαCD19Cre or littermate controls. (e,F) Quantification of S1P1 transcript levels in the (e) T2 B cells and (F) MZ B cells from 
dnRARαCD19Cre or control mice. Three independent experiments with at least seven mice/group. (g,h) Quantification of S1P1 transcript levels in wild type  
(g) T2 B cells and (h) MZ B cells treated with 1 µM of LE135m, or untreated. (i,J) Chemotaxis assay of wild type MZ B cells treated with 1 µM of LE135, or 
untreated, to (i) 100 nM of S1P or to (J) 250 nM SDF-1. Three independent experiments with at least two to three mice/group. ***p < 0.001 and **p < 0.01.
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of MZ B cells in the spleen of dnRARαCD19Cre mice compared 
to control mice (Figures  1C–E). We then analyzed the splenic 
architecture by histology in dnRARαCD19Cre mice. The data 
shown in Figure 1F demonstrates a reduction in MZ B cells in 
the spleen of dnRARαCD19Cre mice compared to littermate con-
trols. In addition, no difference was found in MHC-II, CD80 or 
CD86 expression in B cells from dnRARαCD19Cre and littermate 
controls (data not shown). Together, these data suggest that RA 
signaling in B cells is necessary for the development of MZ B cells.
ra signaling regulates s1P1 expression  
in MZ B cells
It has been previously reported that the integrins αLβ2 and α4β1 
facilitate long-term retention of B cells in the MZ (31). We 
assessed whether RA signaling in B cells affects the expression of 
these integrins in MZ B cells or T2 B cells. Our results showed no 
difference in the expression of these integrins in any of the studied 
B cell subsets (Figures  2A–D). Another molecule involved in 
the migration of B cells to the MZ is S1P1 (28). We evaluated 
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S1P1 expression on T2 and MZ B cells from dnRARαCD19Cre 
mice and observed that it was drastically increased in T2 B cells 
(Figure 2E), but reduced in MZ B cells from dnRARαCD19Cre 
mice compared with littermate controls (Figure  2F). Together, 
these results suggest that RA signaling is necessary to regulate the 
expression of S1P1 in T2 and MZ B cells.
In order to evaluate whether RA signaling in MZ B cells affects 
migration to S1P, we sought perform chemotaxis assays using MZ 
B cells from dnRARαCD19Cre. However, due to low cell numbers, 
it was not possible to perform ex vivo chemotaxis assays with cells 
from dnRARαCD19Cre (unpublished data). Instead, we compared 
wild-type MZ B cells treated with LE135, an antagonist for RAR 
signaling, to untreated wild-type MZ B cells (27). First, we evalu-
ated whether LE135 affects S1P1 expression in B cells. As observed 
in T2 and MZ B cells from dnRARαCD19Cre mice (Figures 2E,F), 
LE135 increased the expression of S1P1 in T2 B cells (Figure 2G) 
whereas S1P1 expression in MZ B cells treated with LE135 was 
reduced (Figure  2H). In addition, LE135 treatment drastically 
reduced the ability of MZ B cell to respond to S1P (Figure 2I), 
without affecting the chemotaxis to SDF-1 (Figure 2J). Together, 
these results suggest that RA signaling in B cells plays an impor-
tant role in the expression of S1P1 and induces S1P-mediated 
chemotaxis in MZ B cells.
ra signaling in B cells is necessary for 
B1 B cell generation and for  
T cell-independent immune responses
RA signaling in B cells is important for IgA plasma cell dif-
ferentiation and to maintain IgA titers in the gut (24). In addi-
tion, it has been proposed that peritoneal B cells migrate from 
the peritoneum to the lamina propria of the small intestine to 
contribute to IgA antibody levels in the gut (32, 33). Thus, we 
studied whether RA signaling in B cells could also affect the 
generation of peritoneal B cells. We observed a 60% reduction 
in the proportion of B1a and B1b B cells in the peritoneum of 
dnRARαCD19Cre mice compared to controls (Figures  3A–D), 
which suggests that RA signaling is necessary in B cells for the 
generation or migration of B1 B cells.
The main function of B1 and MZ B cells is the T cell-
independent production of antibodies against blood-borne 
particulate antigens (34, 35). Since RA signaling in B cells affects 
the frequency of MZ and B1 B cells, we analyzed whether the 
absence of RA signaling affects the T-independent humoral 
response. To address this, we immunized dnRARαCD19Cre and 
control mice with TNP-Ficoll and collected serum at different 
time points to quantify anti-TNP antibodies by ELISA. We 
observed a decrease in both anti-TNP IgM and IgG3 titers in the 
dnRARαCD19Cre mice compared to controls (Figures 3E,F). This 
reduction in Ag-specific antibody levels correlated with a reduc-
tion in anti-TNP IgM and anti-TNP IgG3 ASCs (Figures 3G,H). 
In contrast, no difference was observed in the number of 
anti-TNP-IgG1 ASC between dnRARαCD19Cre and littermate 
control mice immunized with TNP-KLH and alum to induce a 
T-dependent humoral response (Figure 3I). In summary, these 
results suggest that RA signaling in B cells is important for the 
generation of T-independent humoral responses.
ra signaling in B cells Does not affect  
B cell Development in the Bone Marrow
To assess whether RA signaling affects the development of B cells 
in the bone marrow, we quantified the percentage and absolute 
numbers of pre-B cells (B220+IgMnegIgDneg), immature B cells 
(B220+IgMhiIgDneg), and mature B cells (B220+IgMintIgD+) in 
dnRARαCD19Cre mice, as previously described (29). Our results 
showed an increase in the percentage of immature B cells in 
dnRARαCD19Cre mice compared with controls (Figure  4B). 
However, there was no difference in the absolute number of 
immature B cells (Figure 4E). In addition, neither the proportion 
nor the number of pre/pro B cells and mature B cells were affected 
by the abrogation of RA signaling in B cells (Figures 4A,C,D,F). 
These results indicate that B cell intrinsic RA signaling does not 
have an impact in the early development of B cells in the bone 
marrow.
DiscUssiOn
Vitamin A deficiency has a major impact on T and B cell immu-
nity. For example, deficiency in vitamin A drastically increases 
the mortality rate from measles (10) and the incidence of diarrhea 
(11). Moreover, supplementation in vitamin A or retinol reduces 
measles-related mortality and diarrhea in children (36, 37). Until 
now, the direct effect of RA on B cell function in protection 
against infection was unknown.
It has previously been published that human and mouse B cells 
express RARα (38); however, no detailed analysis of RAR expres-
sion in splenic B cells subsets has been reported. Our results show 
that RARα is expressed in all splenic B cell subsets; however, 
RARβ and γ isoforms are not expressed in these subsets. In addi-
tion, using a transgenic mouse model, in which RARα signaling 
is abrogated specifically in B cells, we demonstrate a profound 
defect in the development of MZ B cells and B1 B cells in vivo, 
which has a severe impact on T-independent humoral responses. 
This effect was not due to inhibition of the early development of 
B cells in the bone marrow, rather, RA signaling regulated the 
expression of S1P1 in T2 and MZ B cells and could, therefore, 
regulate MZ B cell development.
Our results demonstrated a reduction in the proportion of MZ 
B cells in the spleen and B1 B cells in the peritoneum when RA 
signaling was abrogated in B cells. Thus, we can hypothesize two 
different roles for RA; first, RA plays a role in B cell homing to the 
MZ and peritoneum, second, that RA regulates the development 
of both B1 and MZ B cells. It is well characterized that RA plays 
an important role in B cell migration to the gut by inducing the 
expression of α4β7 and CCR9 (24, 39). Thus, RA may also play 
a role in B cell migration to both MZ and peritoneum. It has 
previously been reported that integrins and S1P1 play an essential 
role in the localization of B cells to the MZ and peritoneum (28, 
31, 40). Our results show that RA signaling is required for S1P1 
expression in MZ B cells. In addition, we observed that chemot-
axis to the ligand S1P is affected when RA signaling is abrogated 
in B cells. Therefore, our results support the idea that RA signal-
ing promotes S1P1 expression in MZ B cells and, therefore, may 
affect the localization of B cells into the MZ.
FigUre 3 | B1 B cells are reduced and the T-independent humoral response is inhibited in the absence of ra signaling in the B cell compartment. 
(a,c) Representative contour plot of (a) B1 (CD11b+ IgM+) and (c) B1a (CD5+ IgM+) B cells from dnRARαCD19Cre and control mice are shown. The numbers in 
the corners of the plots represent the percentage of total B cells. The cells were pre-gated on live B220+ cells. Quantification of (B) B1 B cells and (D) B1a B cells in 
peritoneal lavage from dnRARαCD19Cre and control mice. (e,F) Quantification of (e) TNP-IgM and (F) TNP-IgG3 titers in serum by ELISA. (g–i) Number of (g) 
TNP-IgM, (h) TNP-IgG3, and (i) TNP-IgG1 antibody-secreting cell, as detected by ELISPOT, in the spleen are shown. Three independent experiments with at least 
eight mice/group. **p < 0.01, ***p < 0.001, and ****p < 0.0001.
7
Marks et al. RA Effect on T-Independent B Cell Responses
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 643
Alternatively, RA may also play a role in B cell differentiation. 
It has been reported that RA inhibits B cell proliferation follow-
ing BCR stimulation in both mouse and humans (41, 42). RA 
could play a role in reducing BCR signal strength in T2 B cells 
to promote MZ B cell differentiation, compared to FO B cells 
(43). This regulation could occur by three potential mechanisms; 
controlling the expression of negative regulators of BCR signaling 
(44), regulation of BAFF receptor, and NF-κB signaling (45) and/
or be involved regulating Notch pathway (5).
Our results do not support a role for RA signaling in bone 
marrow development of B cells. MZ B cells are derived from bone 
marrow precursors (43); however, we found no changes in mature 
FigUre 4 | ra signaling in B cells does not affect B cell development in the bone marrow. Bone marrow from dnRARαCD19Cre and control mice were 
obtained and pre/pro, immature and mature B cells were analyzed. (a–c) Percentage of the indicated B cell subsets of total live B cells in the bone marrow. (D–F) 
Absolute number. Three independent experiments with at least eight mice/group. *p < 0.05.
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B cells in the bone marrow of dnRARαCD19Cre mice, providing 
evidence that there is no effect of RA signaling on bone marrow 
B cell differentiation.
B1 B cells are developed prior to the first few weeks after birth 
(7). It has been demonstrated that B1 B cells can be reconstituted 
from fetal liver but not from bone marrow (46), suggesting that 
B1 B cell development takes place during embryogenesis. Our 
results showed a reduction in B1 B cells in the peritoneum of 
dnRARαCD19Cre mice compared to controls, indicating a role for 
RA in B1 B cell development. NFATc1 has been implicated in 
this process (47) and NFATc1 expression in B1 B cells has been 
observed to be effected with vitamin A deficiency (21). Further 
studies to determine whether RAR binds directly to the NFATc1 
promotor are needed.
Our results show that RA signaling in B cells is necessary for 
an effective T-independent B cell response, confirming previous 
studies showing vitamin A deficiency reduces T-independent 
responses to pneumococcal polysaccharides (48). Moreover, 
our results support several studies demonstrating the adjuvant 
impact of ATRA to enhance immunity.
Similarly to T cells (49), B cells can be re-educated in the 
acquisition of homing receptors in a RA-dependent manner 
(39). This plasticity could be used by naïve or memory B-cells 
to induce/inhibit migration to the spleen or other tissues. Such 
an effect has been demonstrated by He and collaborators, where 
intestinal epithelial cells and dendritic cells, which express retinal 
dehydrogenase enzymes and are able to produce RA, were shown 
to promote T-independent immune responses by regulating 
isotype switching from IgM or IgG to IgA plasma cells (50). 
Similarly, ATRA in combination with Vivotif results in increased 
IgA titers against typhoid (51).
Given the importance of RA in the migration and differen-
tiation of B cells, it is relevant to determine which cells induce 
these properties on B lymphocytes. Dendritic cells from the 
lamina propria express a specific retinal dehydrogenase enzyme, 
which is essential for the synthesis of RA (52–54). Nonetheless, 
dendritic cells are not the only population of cells capable of 
synthesis of RA in the gut; macrophages and intestinal epithelial 
cells also express retinal dehydrogenase enzymes and are able to 
produce RA (53, 55, 56). However, it is unknown whether splenic 
macrophages play a role in the generation or migration of MZ 
B cells.
In conclusion, this study shows the important role of RA 
signaling in B cells for the generation of T-independent immune 
responses, with implications for the generation of new protocols 
for the use of ATRA as a novel adjuvant in vaccines.
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